Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predicting Stage Progression in Binet Stage a Chronic Lymphocytic Leukemia.

Hematology/oncology and stem cell therapy - 22 Mar 2024

Alshemmari Salem H, Almazyad Mazyad, Alsarraf Ahmed, Kunhikrishnan Anita, Isaac Asha M, Kaempf Andy

Abstract excerpt

INTRODUCTION: The variable clinical course of chronic lymphocytic leukemia (CLL) and the lack of consensus on follow-up and treatment strategies have necessitated a prognostic model for identifying high-risk patients at the time of diagnosis. METHODS: We involved a retrospective analysis of demographic and clinical characteristics of 212 patients diagnosed with Binet stage A CLL and thus eligible for risk...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leukemia, Lymphocytic, Chronic, B-Cell
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Source

Identifiers

PMID: 38560969
DOI: 10.56875/2589-0646.1117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predicting Stage Progression in Binet Stage a Chronic Lymphocytic Leukemia.PMID 38560969Read ↗

Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.Semantic proximity Read ↗

Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.Semantic proximity Read ↗

Defining the prognosis of early stage chronic lymphocytic leukaemia patients.Semantic proximity Read ↗

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.Semantic proximity Read ↗

Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia.Semantic proximity Read ↗

Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia.Semantic proximity Read ↗

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemiaSemantic proximity Read ↗

Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?Semantic proximity Read ↗

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.Semantic proximity Read ↗

A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable diseaseSemantic proximity Read ↗

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemiaSemantic proximity Read ↗

White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.